Rain Oncology Inc. Stock-Based Compensation
Rain Oncology Inc. reported Stock-Based Compensation of $3.63 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2023-11-09
- Rain Oncology Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-09-30 was $1.23M, a 31.76% increase year-over-year.
- Rain Oncology Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-06-30 was $837.00K, a 40.93% decline year-over-year.
- Rain Oncology Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-03-31 was $1.57M, a 26.25% increase year-over-year.
- Rain Oncology Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-12-31 was $1.26M, a 0.63% decline year-over-year.
- Rain Oncology Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $4.86M, a 57.02% increase from fiscal 2021.
- Rain Oncology Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $3.09M, a 257.46% increase from fiscal 2020.
- Rain Oncology Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $865.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.06M derived: sum of 2 quarters · filed 2023-11-09 | $3.63M 10-Q · filed 2023-11-09 | $4.90M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | $837.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.40M 10-Q · filed 2023-08-10 | $3.67M derived: sum of 3 quarters · filed 2023-08-10 | $4.60M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | $1.57M 10-Q · filed 2023-05-11 | $2.83M derived: sum of 2 quarters · filed 2023-05-11 | $3.76M derived: sum of 3 quarters · filed 2023-11-09 | $5.18M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.20M derived: sum of 2 quarters · filed 2023-11-09 | $3.61M derived: sum of 3 quarters · filed 2023-11-09 | $4.86M 10-K · filed 2023-03-09 |
| 2022-09-30 | $932.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.35M derived: sum of 2 quarters · filed 2023-11-09 | $3.59M 10-Q · filed 2023-11-09 | $4.86M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.66M 10-Q · filed 2023-08-10 | $3.93M derived: sum of 3 quarters · filed 2023-08-10 | $4.79M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.24M 10-Q · filed 2023-05-11 | $2.51M derived: sum of 2 quarters · filed 2023-05-11 | $3.38M derived: sum of 3 quarters · filed 2023-05-11 | $4.17M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.13M derived: sum of 2 quarters · filed 2023-03-09 | $2.93M derived: sum of 3 quarters · filed 2023-03-09 | $3.09M 10-K · filed 2023-03-09 |
| 2021-09-30 | $862.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.66M derived: sum of 2 quarters · filed 2022-11-10 | $1.82M 10-Q · filed 2022-11-10 | $2.09M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $793.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $958.00K 10-Q · filed 2022-08-04 | $1.23M derived: sum of 3 quarters · filed 2022-08-04 | $1.43M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $165.00K 10-Q · filed 2022-05-04 | $434.00K derived: sum of 2 quarters · filed 2022-05-04 | $635.00K derived: sum of 3 quarters · filed 2022-05-04 | $831.00K derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $269.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $470.00K derived: sum of 2 quarters · filed 2022-03-03 | $666.00K derived: sum of 3 quarters · filed 2022-03-03 | $865.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | $201.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $397.00K derived: sum of 2 quarters · filed 2021-11-10 | $596.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $395.00K 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $199.00K 10-Q · filed 2021-05-25 |